SUTENT 37.5 mg/1
Sunitinib malate · CAPSULE · Pfizer Laboratories Div Pfizer Inc
No Recall History
Plain English
SUTENT is a capsule containing sunitinib malate at 37.5 mg/1, taken oral. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- SUTENT
- Generic Name
- Sunitinib malate
- NDC Code (Product)
0069-0830- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 37.5 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA021938
- Marketing Start
- 07/12/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is SUTENT used for?
SUTENT contains Sunitinib malate. It is a capsule taken oral. Consult your doctor for specific uses.
Is SUTENT a controlled substance?
SUTENT is not classified as a controlled substance by the DEA.
What is the generic name for SUTENT?
The generic name for SUTENT is Sunitinib malate. There are 11 other brand versions of Sunitinib malate.
What is the NDC code for SUTENT 37.5 mg/1?
The NDC (National Drug Code) for SUTENT 37.5 mg/1 is 0069-0830, listed by Pfizer Laboratories Div Pfizer Inc.
Other SUTENT Dosages
Other Sunitinib Brands
See all →- Sunitinib Malate12.5 mg/172205-116
- Sunitinib Malate50 mg/182293-017
- Sunitinib Malate37.5 mg/10378-6681
- Sunitinib malate50 mg/116714-679
- SUNITINIB MALATE37.5 mg/143598-047
- Sunitinib malate50 mg/163304-094
- Sunitinib Malate25 mg/172205-117
- Sunitinib Malate50 mg/172205-119
- Sunitinib Malate37.5 mg/182293-016
- SUNITINIB MALATE12.5 mg/143598-045
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)